A scoping review in Cureus (2025) added important context: dual-acting agonists like tirzepatide which targets both GLP-1 and GIP receptors produced greater reductions in weight and insulin sensitivity than GLP-1-only agents
Reviewing Recent Studies on GLP-1 Drugs and Hair Loss Recent studies investigating the relationship between GLP-1 drugs and hair loss have yielded mixed results, with some indicating a potential correlation while others present limited evidence
According to FDA prescribing information, tirzepatide can be administered at any time of day, with or without meals
Full tummy tuck This lady is in her mid-40s
Investigational drug Retatrutide has not been approved by the FDA
Vitamin injections can also prove beneficial for patients with certain symptoms and conditions, such as chronic pain, fatigue, headaches, insomnia, allergies, digestive problems, asthma, and diabetes